// App-Quantinova.ai

: Late Breaking Abstract - Dupilumab long-term safety and efficacy in patients with asthma: LIBERTY ASTHMA TRAVERSE

Researchers

Presenter

  • Michael E. Wechsler

Principal Investigators

  • Jorge F. Maspero

  • Ian D. Pavord

  • Yuji Tohda

  • David Langton

  • Christian Domingo

  • Alberto Papi

  • Arnaud Bourdin

  • Henrik Watz

  • Hae Sim Park

  • Kenneth R. Chapman

  • Xuezhou Mao

  • Benjamin Ortiz

  • Michel Djandji

  • Upender Kapoor

  • Faisal A. Khokhar

  • Leda P. Mannent

  • Marcella Ruddy

  • Elizabeth Laws

  • Nikhil Amin

  • Megan Hardin

Medical Centers

  • National Jewish Health, Denver, CO, United States

  • Asthma & Allergy Center, Bellevue, United States of America

  • Fundacion GADOR, Buenos Aires, Argentina

  • NIHR Oxford Biomedical Research Centre, Oxford University, Oxford, United Kingdom.

  • Kindai University, Osakasayama, Osaka, Japan

  • Frankston Hospital, Frankston, Australia

  • Corporació Sanitaria Parc Taulí, Sabadell, Barcelona, Spain

  • Respiratory Medicine Unit, University of Ferrara, S. Anna University Hospital, Ferrara, Italy

  • Université de Montpellier, CHU Montpellier, PhyMedExp, INSERM, CNRS, Montpellier, France

  • Pulmonary Research Institute at LungenClinic Großhansdorf, Airway Research Center North, German Center for Lung Research, Großhansdorf, Germany,

  • Ajou University, Suwon, Republic of Korea

  • University of Toronto, Toronto, ON, Canada

  • Sanofi US, Bridgewater, United States of America

  • Regeneron Pharmaceuticals - Tarrytown - United States of America

  • Sanofi, Chilly-Mazarin, France

Locations

  • United States

  • Argentina

  • United Kingdom

  • Japan

  • Australia

  • Spain

  • Italy

  • France

  • Germany

  • Republic of South Korea

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Asthma

Biomarkers

  • N/A

Drug/Treatment

  • Dupilumab

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • NCT02134028

Sponsors

  • N/A

Result

  • N/A